↓ Skip to main content

Dove Medical Press

Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis

Overview of attention for article published in Drug Design, Development and Therapy, October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
23 Mendeley
Title
Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
Published in
Drug Design, Development and Therapy, October 2018
DOI 10.2147/dddt.s176021
Pubmed ID
Authors

Luping Wang, Canwei Zhang, Rui Hua

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 22%
Student > Bachelor 3 13%
Researcher 2 9%
Professor 1 4%
Student > Master 1 4%
Other 1 4%
Unknown 10 43%
Readers by discipline Count As %
Medicine and Dentistry 8 35%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Nursing and Health Professions 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Sports and Recreations 1 4%
Other 1 4%
Unknown 10 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2020.
All research outputs
#8,626,132
of 25,604,262 outputs
Outputs from Drug Design, Development and Therapy
#650
of 2,271 outputs
Outputs of similar age
#142,267
of 355,286 outputs
Outputs of similar age from Drug Design, Development and Therapy
#20
of 61 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,286 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.